tiprankstipranks
Advertisement
Advertisement
Sagimet Biosciences price target lowered to $12 from $35 at Citizens
PremiumThe FlySagimet Biosciences price target lowered to $12 from $35 at Citizens
2M ago
Options Volatility and Implied Earnings Moves This Week, May 18 – May 22, 2026
Premium
Market News
Options Volatility and Implied Earnings Moves This Week, May 18 – May 22, 2026
2M ago
SGMT Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
SGMT Upcoming Earnings Report: What to Expect?
2M ago
Sagimet Biosciences price target raised to $33 from $28 at Oppenheimer
PremiumThe FlySagimet Biosciences price target raised to $33 from $28 at Oppenheimer
2M ago
Sagimet Therapeutics: Buy Rating Reiterated on Denifanstat’s First-Line Acne Potential; $28 Price Target Unchanged
Premium
Ratings
Sagimet Therapeutics: Buy Rating Reiterated on Denifanstat’s First-Line Acne Potential; $28 Price Target Unchanged
2M ago
Sagimet Biosciences management to meet virtually with Clear Street
Premium
The Fly
Sagimet Biosciences management to meet virtually with Clear Street
2M ago
Sagimet Biosciences Announces Major Equity Offering for Pipeline
PremiumCompany AnnouncementsSagimet Biosciences Announces Major Equity Offering for Pipeline
2M ago
Sagimet Updates Investor Presentation After Key Clinical Milestones
Premium
Company Announcements
Sagimet Updates Investor Presentation After Key Clinical Milestones
2M ago
Sagimet Highlights Pipeline Progress and Strategic Corporate Developments
Premium
Company Announcements
Sagimet Highlights Pipeline Progress and Strategic Corporate Developments
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100